PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32876513-7 2021 The IGF2BP1-SRC/ERK2 axis is targetable by the SRC-inhibitor saracatinib and MEK-inhibitor selumetinib. AZD 6244 91-102 insulin-like growth factor 2 mRNA binding protein 1 Mus musculus 4-11